- Home
- ATHA vs STI Comparison
ATHA vs STI Comparison
Compare ATHA & STI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- STI
- Stock Information
- Founded
- ATHA 2011
- STI 2014
- Country
- ATHA United States
- STI United States
- Employees
- ATHA N/A
- STI N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- STI
- Sector
- ATHA Health Care
- STI
- Exchange
- ATHA Nasdaq
- STI NYSE
- Market Cap
- ATHA 10.6M
- STI 9.5M
- IPO Year
- ATHA 2020
- STI N/A
- Fundamental
- Price
- ATHA $0.31
- STI $4.34
- Analyst Decision
- ATHA Buy
- STI
- Analyst Count
- ATHA 4
- STI 0
- Target Price
- ATHA $11.25
- STI N/A
- AVG Volume (30 Days)
- ATHA 1.3M
- STI 79.3K
- Earning Date
- ATHA 07-31-2025
- STI 08-12-2025
- Dividend Yield
- ATHA N/A
- STI N/A
- EPS Growth
- ATHA N/A
- STI N/A
- EPS
- ATHA N/A
- STI 6.72
- Revenue
- ATHA N/A
- STI N/A
- Revenue This Year
- ATHA N/A
- STI N/A
- Revenue Next Year
- ATHA N/A
- STI N/A
- P/E Ratio
- ATHA N/A
- STI $0.64
- Revenue Growth
- ATHA N/A
- STI N/A
- 52 Week Low
- ATHA $0.22
- STI $2.94
- 52 Week High
- ATHA $3.67
- STI $55.00
- Technical
- Relative Strength Index (RSI)
- ATHA 49.52
- STI 57.41
- Support Level
- ATHA $0.29
- STI $3.22
- Resistance Level
- ATHA $0.35
- STI $3.93
- Average True Range (ATR)
- ATHA 0.03
- STI 0.30
- MACD
- ATHA -0.00
- STI 0.16
- Stochastic Oscillator
- ATHA 14.10
- STI 81.07
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About STI SOLIDION TECHNOLOGY INC
Solidion Technology Inc is engaged in researching, developing and manufacturing battery materials and components, as well as the development and production of next-generation batteries for energy storage systems and electric vehicles for ground, air, and sea transportation. It is recognized as a IP leader in both the high-capacity anode and the high-energy solid-state battery.